Subscribe

Deep Dives

Why Regeneron Pharmaceuticals Inc (NASDAQ: REGN) is a biotech force to be reckoned with

Regeneron was founded in 1988 by Dr. Leonard S Schleifer. Dr. Schelifer shared, that the name Regeneron came from “Regenerating neurons, with the word “gene” in the middle”. The origin of the name further explains that the initial focus of the company was neurobiology. Then in 1990 following the publication

Alnylam Pharmaceuticals (NASDAQ: ALNY) Stock Deep Dive

A Biotech Growth Stock to Consider For Your Portfolio - Sarepta Therapeutics (NASDAQ: SRPT)

A Biotech Growth Stock to Consider For Your Portfolio - Sarepta Therapeutics (NASDAQ: SRPT)

Is Vertex Pharmaceuticals the next blue chip biotech?

A Deep Dive Into a Pioneer in CRISPR Gene Editing (CRISPR Therapeutics)

A Deep Dive Into a Pioneer in CRISPR Gene Editing (CRISPR Therapeutics)

Head-to-head in the space of proteomics: Quantum Si (NASDAQ: QSI) vs Nautilus Biotechnology (NASDAQ: NAUT)

Head-to-head in the space of proteomics: Quantum Si (NASDAQ: QSI) vs Nautilus Biotechnology (NASDAQ: NAUT)

What is proteomics? During the expression of a protein-coding gene, information flows from DNA → RNA →protein. This directional flow of information is known as the central dogma of molecular biology. (Learn more about DNA and RNA in our previous articles.) Proteomics, in simple terms, is the study of proteins.